0000876661-17-000383.txt : 20170705 0000876661-17-000383.hdr.sgml : 20170705 20170705110626 ACCESSION NUMBER: 0000876661-17-000383 CONFORMED SUBMISSION TYPE: 25-NSE PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20170705 DATE AS OF CHANGE: 20170705 EFFECTIVENESS DATE: 20170705 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Envision Healthcare Corp CENTRAL INDEX KEY: 0001678531 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 621493316 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25-NSE SEC ACT: 1934 Act SEC FILE NUMBER: 001-37955 FILM NUMBER: 17946566 BUSINESS ADDRESS: STREET 1: 1A BURTON HILLS BOULEVARD CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615-665-1283 MAIL ADDRESS: STREET 1: 1A BURTON HILLS BOULEVARD CITY: NASHVILLE STATE: TN ZIP: 37215 FORMER COMPANY: FORMER CONFORMED NAME: New Amethyst Corp. DATE OF NAME CHANGE: 20160629 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC CENTRAL INDEX KEY: 0000876661 IRS NUMBER: 000000000 STATE OF INCORPORATION: NY FILING VALUES: FORM TYPE: 25-NSE BUSINESS ADDRESS: STREET 1: 11 WALL STREET CITY: NEW YORK STATE: NY ZIP: 10005 BUSINESS PHONE: 212-656-2060 MAIL ADDRESS: STREET 1: 11 WALL STREET CITY: NEW YORK STATE: NY ZIP: 10005 FORMER COMPANY: FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC DATE OF NAME CHANGE: 19910628 25-NSE 1 primary_doc.xml X0203 0000876661 NEW YORK STOCK EXCHANGE LLC 1678531 Envision Healthcare Corp 001-37955

6363 S. Fiddler's Green Circle Suite 1400 Greenwood Village CO COLORADO 80111

(615) 665-1283 5.250% Mandatory Convertible Preferred Stock, Series A-1 17 CFR 240.12d2-2(a)(3) Benjamin Sawyer Manager 2017-07-05 EX-99.25 2 ruleprovisionnotice.htm NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on July 17, 2017, pursuant to the provisions of Rule 12d2-2 (a). [ X ] 17 CFR 240.12d2-2(a)(3) That on July 1, 2017 the instruments representing the securities comprising the entire class of this security came to evidence, by operation of law or otherwise, other securities in substitution therefore and represent no other right except, if such be the fact, the right to receive an immediate cash payment. The mandatory conversion in Envision Healthcare Corporation 5.250% Mandatory Convertible Preferred Stock, Series A-1 ('EVHC PR'), became effective July 1, 2017. All outstanding shares of Envision Healthcare Corporation 5.250% Mandatory Convertible Preferred Stock, Series A-1 ('EVHC PR'), will be converted into shares of Common Stock with a conversion rate of between 1.8141 and 2.2222 shares of Common Stock per share of 'EVHC PR', depending on the market price of common stock over a period of 20 consecutive trading days prior to July 1, 2017. The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on July 3, 2017.